Our market cap is nearly 500M, we have no revenue for the next 2 years and tons of debt. We are running additional trials for the FDA after 2 CRL's. Approval looks 18 months out. We are running out of money. Inhaled insulin has failed misably in the past. Lots of partnership talk...no takers. There are plenty of reasons this stock is at $2. On paper...it looks like investment suicide. It is only you, I and anyone else who has invested that realizes the true game changing potential. But...it is still only potential and there is still a lot to overcome. Most of the mass market...including many of my friends in the pharma industry...still think this is going to fail. It is only when you truly dig into the science that you can think differently. I don't think most have done that and the financials don't meet the screens of the big institutional folks. It is only speculative investors right now. This will have serious momentum when it does go. I assess an 80/20 probability we see at least $20 a share within 3-5 years. I'll take those odds.